AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vogjak MG 2mg/500mg/0.3mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Jakstar Pharma

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Vogjak MG 2mg/500mg/0.3mg Tablet SR

Diabexe MG 2mg/500mg/0.3mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy is indicated for managing type 2 diabetes in adults, helping regulate blood glucose. Diabexe MG should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan, encompassing a balanced diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. The most frequent adverse event associated with Diabexe MG is hypoglycemia (low blood sugar). Learn to recognize its symptoms – sweating, lightheadedness, headache, tremors – and appropriate countermeasures. Maintain regular mealtimes and carry a readily available glucose source (e.g., sugary snacks, juice). Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or lactating women should seek medical consultation before use. Regular blood glucose monitoring is essential, and your doctor may recommend blood tests to assess blood cell counts and liver function.

Uses of Vogjak MG 2mg/500mg/0.3mg Tablet SR

Managing Type 2 Diabetes

Major Benefits of Vogjak MG 2mg/500mg/0.3mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Vogjak MG 2mg/500mg/0.3mg SR Tablet whole; do not break, crush, or chew it. Administer on an empty stomach.

Common Side effects of Vogjak MG 2mg/500mg/0.3mg Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Vogjak MG 2mg/500mg/0.3mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the Vogjak MG 2mg/500mg/0.3mg Tablet SR whole; avoid chewing, crushing, or fracturing. Administer on an empty stomach.

How Vogjak MG 2mg/500mg/0.3mg Tablet SR works:

Each Vogjak MG SR tablet (2mg/500mg/0.3mg) contains a triple-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Vogjak MG 2mg/500mg/0.3mg Tablet SR with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Vogjak MG tablet (2mg/500mg/0.3mg) might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers before prescribing it. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Vogjak MG tablets (2mg/500mg/0.3mg) are likely unsafe for breastfeeding mothers. Available evidence from humans indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyUNSAFE

Patients with kidney impairment should likely avoid Vogjak MG 2mg/500mg/0.3mg Tablet SR, as its use may be unsafe. Medical advice is recommended. Furthermore, this medication is unsuitable for individuals with severe kidney disease.

LiverLiverCAUTION

Patients with liver impairment should use Vogjak MG 2mg/500mg/0.3mg SR tablets cautiously, as dose modification may be necessary. Consult a physician. For those with mild to moderate hepatic dysfunction, initiation should be at a reduced dosage; the medication is contraindicated in patients with severe liver disease.

What if you forget to take Vogjak MG 2mg/500mg/0.3mg Tablet SR :

Should you forget a Vogjak MG 2mg/500mg/0.3mg Tablet SR dose, take it immediately if remembered. However, near the time for your next scheduled dose, omit the missed dose and resume your usual dosing pattern. Never take more than the prescribed amount at one time.

Facts to Know About Vogjak MG 2mg/500mg/0.3mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Vogjak MG 2mg/500mg/0.3mg Tablet SR

Vogjak MG SR tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release, metformin reduces liver glucose production and enhances insulin sensitivity, and voglibose inhibits alpha-glucosidase, lowering postprandial glucose. This medication is not for type 1 diabetes.
Vogjak MG 2mg/500mg/0.3mg SR Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, taste changes, flatulence, stomach pain, headache, rash, and respiratory infections.
Vogjak MG 2mg/500mg/0.3mg Tablet SR is contraindicated in patients allergic to its components or excipients, those with moderate to severe kidney disease, and those with inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis (including diabetic ketoacidosis).
Combining Vogjak MG 2mg/500mg/0.3mg Tablet SR with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Vogjak MG 2mg/500mg/0.3mg Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Vogjak MG 2mg/500mg/0.3mg...
131
MRP 160
18% off